Latest News about INBX
Recent news which mentions INBX
Around $2M Bet On Franklin Resources? Check Out These 4 Stocks Executives Are Buying
September 03, 2024
From Benzinga
Over $7M Bet On This Health Care Stock? Check Out These 3 Stocks Executives Are Buying
August 27, 2024
From Benzinga
INBX Stock Earnings: Inhibrx Biosciences Beats EPS for Q2 2024
August 14, 2024
Tickers
INBX
From InvestorPlace
From Benzinga
French Drugmaker Sanofi Agrees To Buy Inhibrx's Candidate For Rare Genetic Indication, For About $2.2B
January 23, 2024
From Benzinga
Olympic Sponsor Sanofi Makes Major Play In Rare Disease Arena $2.2 Billion Acquisition Of Inhibrx Project
January 23, 2024
From Benzinga
$1.5M Bet On Domo? Check Out These 3 Stocks Insiders Are Buying
August 31, 2023
From Benzinga
Why NIO Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 29, 2023
From Benzinga
PDD Holdings, UP Fintech Holding, Big Lots And Other Big Stocks Moving Higher On Tuesday
August 29, 2023
From Benzinga
JMP Securities Maintains Outperform Rating for Inhibrx: Here's What You Need To Know
August 23, 2023
Tickers
INBX
From Benzinga
Theft in open court: How a fight over lifesaving drugs led to charges of brazen industrial espionage
June 27, 2023
From MarketWatch
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
November 18, 2022
From Benzinga
Inhibrx Posts Updated Efficacy, Safety Data From Expansion Cohorts Of Bone Cancer Candidate
November 16, 2022
Tickers
INBX
From Benzinga
$40 Million Bet On Inhibrx? 3 Stocks Insiders Are Buying
October 13, 2022
From Benzinga
S&P 500 Rises 100 Points; Nasdaq Up 3%
October 04, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 04, 2022
From Benzinga
Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session
October 04, 2022
From Benzinga
Nasdaq Surges 350 Points; Crude Oil Rises Sharply
October 04, 2022
From Benzinga
US Stocks Open Higher As Dow Jumps 550 Points
October 04, 2022
From Benzinga
Inhibrx's Experimental Drug For Inherited Disease Capable For Accelerated FDA Approval, Shares Surge
October 04, 2022
Tickers
INBX
From Benzinga
From Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 15, 2022
From Benzinga
Inhibrx Secures European Commission Orphan Medicinal Product Designation For Bone Cancer Candidate
August 15, 2022
Tickers
INBX
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
June 02, 2022
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|